Abstract
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet‐activating factor (PAF), has been synthesized in 91% overall yield.
Acknowledgment
The results reported here could not have been achieved without a team of experienced and hard working coworkers, who showed real commitment and dedication to the task.